Search
Search
{{#data.error.root_cause}}
{{/data.error}}
{{^data.error}}
{{#texts.summary}}
[{{{type}}}] {{{reason}}}
{{/data.error.root_cause}}{{texts.summary}} {{#options.result.rssIcon}} RSS {{/options.result.rssIcon}}
{{/texts.summary}} {{#data.hits.hits}}
{{#_source.featured}}
FEATURED
{{/_source.featured}}
{{#_source.showImage}}
{{#_source.image}}
{{/_source.image}}
{{/_source.showImage}}
{{/data.hits.hits}}
{{{_source.title}}} {{#_source.showPrice}} {{{_source.displayPrice}}} {{/_source.showPrice}}
{{#_source.showLink}} {{/_source.showLink}} {{#_source.showDate}}{{{_source.displayDate}}}
{{/_source.showDate}}{{{_source.description}}}
{{#_source.additionalInfo}}{{#_source.additionalFields}} {{#title}} {{{label}}}: {{{title}}} {{/title}} {{/_source.additionalFields}}
{{/_source.additionalInfo}}EpiMelt BRCA1 Human Methylation Detection Assay
Cat#: MD-BRCA1-200
Description
-
-
- MD-BRCA1-200 - 200 Reactions
- MD-BRCA1 500 - 500 Reactions
- MD-BRCA1-2500 - 2500 Reactions
-
Publications:
- High prevalence of constitutional BRCA1 epimutation in patients with early-onset triple-negative breast cancer, Schwartz, M., Ibadioune, S., Delhomelle, H. et al., Clin Epigenet 17, 91 (2025)
- Constitutional BRCA1 Methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer. npj Breast Cancer, Pasanisi, J., Lamy, C., Lecompte, L. et al. npj Breast Cancer (2026)
Related Categories
EpiMelt ControlsBoca Scientific is your premiere source for high-quality, innovative solutions for Cell Biology, Molecular Biology, Immunology, genetics and other lab products and reagents. We bring leading-edge products from our own-line and around the world to laboratories in the US and Canada. Our goal is to offer excellent solutions to drive research and discoveries backed by superior customer support.
